Temasek injects $250m in a Chinese healthcare facility

It will form a 50-50 JV with Columbia Pacific.

Singapore's state-owned investment firm is looking forward to expand its healthcare holdings as it invests $250m in the China operations of Columbia Pacific Management.

The two firms will forge a 50-50 joint venture aimed at providing China's growing middle-class population with affordable health and elderly care services.

Columbia Pacific is known for its 40 years of experience in aged and health care. It oversees a network of modern hospitals and senior facilities in several locations in Asia.

The deal bolsters up Temasek's venture in health sector. It has already seen its life sciences and agriculture-related assets double to 4% in the past two years.

To recall, Temasek loaded up on stakes in US pharmaceutical and healthcare firms including Alexion Pharmaceuticals Inc. and Regeneron Pharmaceuticals Inc., which develop treatments for serious medical conditions.

Read more here.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.